Detection of KPC, NDM and VIM-Producing Organisms Directly from Rectal Swabs by a Multiplex Lateral Flow Immunoassay.
carbapenem resistance
carbapenemase detection
carbapenemase-producing organisms
fecal sample
immunochromatography
Journal
Microorganisms
ISSN: 2076-2607
Titre abrégé: Microorganisms
Pays: Switzerland
ID NLM: 101625893
Informations de publication
Date de publication:
27 Apr 2021
27 Apr 2021
Historique:
received:
07
04
2021
revised:
21
04
2021
accepted:
22
04
2021
entrez:
30
4
2021
pubmed:
1
5
2021
medline:
1
5
2021
Statut:
epublish
Résumé
We report a preliminary evaluation of the NG-Test CARBA 5 immunochromatographic assay for detecting carbapenemases directly from rectal swabs on the same day of sampling. Thirty fecal swabs were examined for carbapenemase-producing organisms (CPOs) by conventional culture, PCR, and NG-Test CARBA 5. Each sample was tested by the immunochromatographic assay five times, including direct testing and incubation in trypticase soy broth for 1, 2, 3, and 4 h. Twenty patients yielded CPOs by culture. Immunochromatographic and PCR results were concordant and detected the same 25 carbapenemases (11 KPC, 8 VIM, and 6 NDM). In five cases, we detected co-carriage of KPC and VIM. Compared with PCR, the sensitivity of NG-Test CARBA 5 for the detection of KPC, VIM, and NDM was 80% without incubation, 88% with one hour, 92% with two, and 100% with three hours incubation, while specificity was 100% for all time points. All samples containing adequate fecal content were detected by NG-Test CARBA 5 concordantly with PCR, without incubation. NG-Test CARBA 5 is a reliable test that rapidly detects the presence of carbapenemases at the same day of sampling, directly from rectal swabs. It thus provides early information to guide antimicrobial treatment and infection control interventions.
Identifiants
pubmed: 33925719
pii: microorganisms9050942
doi: 10.3390/microorganisms9050942
pmc: PMC8146855
pii:
doi:
Types de publication
Journal Article
Langues
eng
Références
Diagn Microbiol Infect Dis. 2017 Aug;88(4):293-297
pubmed: 28533001
Infection. 2019 Aug;47(4):673-675
pubmed: 31144273
Lancet Infect Dis. 2019 Jan;19(1):56-66
pubmed: 30409683
J Formos Med Assoc. 2005 May;104(5):318-26
pubmed: 15959598
Clin Microbiol Infect. 2012 May;18(5):439-48
pubmed: 22507111
J Infect Dis. 2017 Feb 15;215(suppl_1):S28-S36
pubmed: 28375512
J Antimicrob Chemother. 2018 Dec 1;73(12):3523-3526
pubmed: 30189008
J Clin Microbiol. 2012 Dec;50(12):3877-80
pubmed: 22993175
Clin Microbiol Rev. 2016 Jan;29(1):1-27
pubmed: 26511484
Ann Intern Med. 2002 Jun 4;136(11):834-44
pubmed: 12044132
Antimicrob Agents Chemother. 2009 Sep;53(9):4048-50
pubmed: 19581459
Front Public Health. 2020 Mar 18;8:55
pubmed: 32257988
J Antimicrob Chemother. 2019 Feb 1;74(2):357-359
pubmed: 30376099